Stock STOK STOKE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Stoke Therapeutics, Inc.

Equities

STOK

US86150R1077

Real-time Estimate Cboe BZX
Other stock markets
 03:39:49 2024-05-23 pm EDT 		5-day change 1st Jan Change
14.8 USD -6.42% Intraday chart for Stoke Therapeutics, Inc. +5.70% +181.94%
May. 22 Stoke Therapeutics Insider Sold Shares Worth $653,529, According to a Recent SEC Filing MT
May. 07 Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
STOKE THERAPEUTICS, INC. Stock Stoke Therapeutics, Inc.
 824M -
MODERNA, INC. Stock Moderna, Inc.
 62.59B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.18B
LONZA GROUP AG Stock Lonza Group AG
 40.29B
CELLTRION, INC. Stock Celltrion, Inc.
 27.9B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.21B
  1. Stock Market
  2. Equities
  3. STOK Stock
  4. Charts Stoke Therapeutics, Inc.
  5. Sector Chart